Search results for "Case Report"

showing 10 items of 771 documents

Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid

2015

Journal Article; Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through complex interventions. Their primary mechanism of action is aimed at the cellular level, inhibiting osteoclast activity and so bone resorption. BPs are widely used, with many patients receiving continuous treatment for years. But it is well known that these drugs can produce osteonecrosis of the jaw (ONJ). Zoledronic acid (ZA) is an intravenous BP used in the treatment and prophylaxis of bone disease in patients with malignant tumors with bone implication. ZA is the most potent BP in clinical development. This report describes the case of a 62-year-old woman with breast cancer antecedents which…

Peri-implantitisBone diseasemedicine.medical_treatmentDifosfonatosDentistryCase Report:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Peri-implantitisDental implant:Chemicals and Drugs::Organic Chemicals::Organophosphorus Compounds::Diphosphonates [Medical Subject Headings]Implantes dentales:Anatomy::Cells::Connective Tissue Cells::Macrophages::Osteoclasts [Medical Subject Headings]ImidazolesOsteonecrosisBisphosphonates:Diseases::Neoplasms [Medical Subject Headings]:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludNeoplasiasHumanosmedicine.anatomical_structureNeoplasias de la mama:Chemicals and Drugs::Biomedical and Dental Materials::Dental Materials::Dental Implants [Medical Subject Headings]UNESCO::CIENCIAS MÉDICASMaxillectomy:Diseases::Stomatognathic Diseases::Mouth Diseases::Peri-Implantitis [Medical Subject Headings]Oral SurgeryResorción óseamedicine.drugmedicine.medical_specialtyOdontología:Diseases::Musculoskeletal Diseases::Bone Diseases::Osteonecrosis [Medical Subject Headings]Bone resorptionBreast cancerOsteoclast:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Azoles::Imidazoles [Medical Subject Headings]medicinePeriimplantitisGeneral DentistryZoledronic acid:Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings]Osteonecrosis of the jawbusiness.industry:Phenomena and Processes::Musculoskeletal and Neural Physiological Phenomena::Musculoskeletal Physiological Phenomena::Musculoskeletal Physiological Processes::Bone Remodeling::Bone Resorption [Medical Subject Headings]Osteoclastosmedicine.diseaseSurgeryZoledronic acid:Check Tags::Female [Medical Subject Headings]Osteonecrosis of the jawbusinessJournal of Clinical and Experimental Dentistry
researchProduct

Laser Therapy for Infected Sites and Immediate Dental Implants in the Esthetic Zone: A Case Report and Review of Literature

2020

Placement of postextraction dental implants has become a common practice. Here, we reviewed current literature, along with clinical procedures, outcomes, and incidence of complications, associated with immediate implants in infected postextraction sites. The YSGG (yttrium, scandium, gallium, and garnet) laser can significantly reduce the bacterial concentration after extracting a compromised tooth. We treated a 40-year-old woman with a compromised tooth in the esthetic zone, presenting clinical and radiological signs of infection, particularly a periapical periodontitis. The tooth was extracted after administering local anesthesia using Optocain® (mepivacaine and adrenalin 1 : 100,000), fol…

Periapical periodontitisbusiness.industryMepivacaineDentistryRK1-715Case Report030206 dentistryBone healingmedicine.disease030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineTreatment successLaser therapyDentistryResorbable membranesmedicineLocal anesthesiaImplantbusinessGeneral Dentistrymedicine.drugCase Reports in Dentistry
researchProduct

A case series associated with different kinds of endo-perio lesions

2014

Pulpal and periodontal problems are responsible for more than half of the tooth mortality. There are some articles published in the literature about this issue. Many of them are quite old. There has been also lack of knowledge about the effect of endodontic treatment on the periodontal tissue healing and suitable treatment interval between endodontic and periodontal treatments. In this case report, different kinds of endo-perio lesion were treated with sequential endodontic and periodontal treatment. The follow-up radiographs showed complete healing of the hard and soft tissue lesions. The tooth with endo-perio lesions should be evaluated thoroughly in terms of any cracks and fracture, espe…

Periodontal treatmentPeriodontal tissuebusiness.industryPeriodontal surgeryTreatment intervalDentistrySoft tissueCase ReportOdontología:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludLesionstomatognathic systemUNESCO::CIENCIAS MÉDICASMedicinePeriodontologyLack of knowledgemedicine.symptombusinessGeneral DentistryMandibular molar
researchProduct

Predictors of tooth loss due to periodontal disease in patients following long‐term periodontal maintenance

2015

The pioneering attempt to characterize the response to periodontal treatment of patients undergoing periodontal maintenance (PM) (Wasserman & Hirschfeld 1988) was soon followed by the first studies on periodontal prognosis (McGuire 1991, McGuire & Nunn 1996a,b, McLeod et al. 1998). Two main conclusions were drawn, which remain generally accepted: establishing a periodontal prognosis is the basis of any treatment plan, and actual knowledge of the predictors of tooth loss (TL) is very limited. An extensive review on the subject noted the heterogeneity of the studies and the scarce information that could be drawn from them (Chambrone et al. 2010). Several statistical models analysing the predi…

Periodontal treatmentperiodontal diseaseDentistryCase ReportPeriodontal TherapyTooth LossPeriodontal diseaseTreatment planTooth lossHumansMedicineLack of knowledgeIn patientPeriodontal maintenanceRetrospective Studiesperiodontal maintenancebusiness.industrySmokingstomatognathic diseasesAggressive PeriodontitisGingival DiseasesPeriodonticsprognosisGood prognosismedicine.symptombusinessDemographyJournal of Clinical Periodontology
researchProduct

Papillon- Lefevre Syndrome: Report of a case and its management

2012

Papillon-Lefèvre Syndrome (PLS) is a rare autosomal recessive disorder first described by two French physicians, Papillon and Lefèvre in 1924. The disorder is characterized by diffuse palmoplantar keratoderma and precocious aggressively progressing periodontitis, leading to the premature loss of deciduous and permanent teeth at a very young age. The cutaneous lesions are usually manifested simultaneously with the intra-oral presentations and include keratotic plaques on the palms and soles varying from mild psoriasiform scaly skin to overt hyperkeratosis. The etiopathogenesis of the syndrome is relatively obscure and immunologic, genetic or possible bacterial etiologies have been proposed. …

PeriodontitisPathologymedicine.medical_specialtybusiness.industryHyperkeratosisCase ReportOdontologíaPapillon–Lefèvre syndrome:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseScaly skinCiencias de la saludDiffuse palmoplantar keratodermaDermatologyYoung ageUNESCO::CIENCIAS MÉDICASmedicineEtiologyOdontostomatology for the Disabled or Special PatientsbusinessGeneral DentistryPermanent teethJournal of Clinical and Experimental Dentistry
researchProduct

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

2019

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm in which clonal proliferation of hematopoietic stem cells and bone marrow fibrosis coexist.1 Patients may eventually die due to leukemic progression, which occurs in up to 20% of cases, or because of cardiovascular comorbidities or cytopenia, which causes susceptibility to infections and bleeding.2 Myelofibrosis diagnosis relies upon the evaluation of several clinical and laboratory criteria suggested by the World Health Organization (WHO) in 2016.3 The major mutations leading to myelofibrosis usually occur in the JAK2, CALR, and MPL genes. However, in almost 10% of the cases, none of the above-mentioned mutations can be detected …

PharmacologyCytopeniamedicine.medical_specialtyRuxolitinibbusiness.industryIPSSruxolitinibprimary myelofibrosilcsh:RM1-950Case ReportGeneral Medicinemedicine.diseaseDiscontinuationPolycythemia veralcsh:Therapeutics. PharmacologyInternational Prognostic Scoring SystemInternal medicinemedicineprimary myelofibrosisMolecular MedicineMyelofibrosisAdverse effectbusinessMyeloproliferative neoplasmmedicine.drugDrugs in Context
researchProduct

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report

2021

Tumour lysis syndrome (TLS) represents a group of fatal metabolic derangements resulting from the rapid breakdown of tumour cells. TLS typically occurs soon after the administration of chemotherapy in haematologic malignancies but is rarely observed in solid tumours. Here, we report a case of brigatinib-induced TLS after treatment with sequential anaplastic lymphoma kinase (ALK) inhibitors in a patient with advanced ALK-rearranged lung adenocarcinoma. The patient was treated sequentially with crizotinib, alectinib, and ensartinib. High-throughput molecular profiling after disease progression indicated that brigatinib may overcome ALK resistance mutations, so the patient was administered bri…

Pharmacologybrigatinibacute kidney injurycase reportPharmacology (medical)Therapeutics. PharmacologyRM1-950targeted therapynon-small cell lung cancertumour lysis syndromeFrontiers in Pharmacology
researchProduct

Sialolithiasis. Proposal for a new minimally invasive procedure: Piezoelectric surgery

2014

Sialolithiasis is the presence of stones in the ducts of the salivary glands. Most episodes are unique, and 60-80% are located exclusively in the main excretory duct. The main clinical manifestations are swelling and pain typically before, during or after meals that decreases if the obstruction is not complete. The highest prevalence of lithiasis is in the submandibular gland -87%-, whose secretion is more viscous, followed by the parotid gland -10%- and finally the sublingual gland -3%-. The most significant consequences are caused by the prolonged blockage of the duct by a stone, which can produce a persistent ductal dilatation with a swelling that does not subside, and could lead to the …

Piezoelectric surgerymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentSecondary infectionSublingual glandSoft tissueOdontologíaCase ReportLithotripsy:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSubmandibular glandParotid glandSurgeryOstiummedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASmedicineOral SurgerybusinessGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

Hypertrophic cardiomyopathy associated with polyarteritis nodosa: A case of sudden cardiac death

2018

This case concerns a rare sudden cardiac death characterized by macroscopic and microscopic postmortem findings of hypertrophic cardiomyopathy and polyarteritis nodosa. A complete autopsy was carried out, and histological and histochemical methods were employed. The cause of death was acute multifocal ischemic myocitolitic damage caused by both myocardial structural alteration attributable to hypertrophic cardiomyopathy (widespread interstitial fibrosis and multifocal myocyte disarray) and coronary arteritis attributable to polyarteritis nodosa. This is the first case in which the cause of death was attributed to both diseases.

Polyarteritis-NodosaSudden cardiac deathCase reportHypertrophic CardiomyopathyForensic pathology
researchProduct

Penetrating aortic ulcer post migration of thoracic aortic endoprosthesis: Case report

2021

Introduction Thoracic endovascular aortic repair (TEVAR) is the first treatment option for many thoracic aortic pathologies. Especially after aortic dissections, it is possible to have progression during follow-up with appearance of new lesions on arterial wall. Herein, we report a case of Penetrating Aortic Ulcer (PAU) post release of Thoracic endoprosthesis. Presentation of case A 67-years-old male with hypertension and diabetes mellitus was followed at our hospital after an emergency procedure for Type B aortic dissection (TBAD) complicated by symptomatic large infrarenal AAA and treated with a proximal TEVAR plus chimney for left subclavian artery and PETTICOAT with EVAR for abdominal a…

Post releasemedicine.medical_specialtyTEVARbusiness.industrymedicine.medical_treatmentStentTreatment optionsmedicine.diseaseAortic diseaseProsthesisSettore MED/22 - Chirurgia VascolareSurgeryPenetrating atherosclerotic ulcerPenetrating atherosclerotic ulcermedicine.arteryCase reportcardiovascular systemmedicineThoracic aortaSurgeryArterial wallComplicated aortic B dissectionbusinessMigration endoprosthesis
researchProduct